Author:
Liang Xiangping,Li Dongpei,Leng Shuilong,Zhu Xiao
Funder
National Natural Science Foundation of China
Southern Science and Engineering Guangdong Laboratory Zhanjiang
Guangdong Provincial Science and Technology Department
The Public Service Platform of South China for R&D Marine Biomedicine Resources
Zhanjiang Science and Technology Plan
“Group-type” Special Supporting Project for Educational Talents in Universities
Subject
Pharmacology,General Medicine
Reference101 articles.
1. RNAi therapeutics: a potential new class of pharmaceutical drugs;Bumcrot;Nat. Chem. Biol.,2006
2. Gene-silencing technology gets first drug approval after 20-year wait;Ledford;Nature,2018
3. FDA approves landmark RNAi drug;Mullard;Nat. Rev. Drug Discov.,2018
4. Pharmacology of antisense drugs;Bennett;Annu. Rev. Pharmacol. Toxicol.,2017
5. RNA-targeted therapeutics;Crooke;Cell Metab.,2019
Cited by
67 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献